Research and Innovation > Clinical Trials Conduct & Transparency
Conduct of Clinical Trials
We are devoted to discovering and developing new medicines. AbbVie's current therapeutic areas of interest are:
- Antiviral (HCV, HIV and RSV)
- Immunology
- Men's Health
- Neuroscience
- Oncology
- Pain
- Renal
- Women's Health
Within each of these therapeutic areas, we have various products in development. The products will change over time as compounds progress through our development program. A critical component of medicinal product development is clinical research, which involves conducting clinical trials in humans to evaluate the safety and efficacy of new products.
Clinical trials can take place prior to the approval of a drug (premarket) and after the approval of a drug (postmarket). Postmarket clinical trials can be conducted on a voluntary basis or be requested by regulators. Those trials which are requested by regulators are called Postmarketing Commitments (PMCs). Click here to view AbbVie's Postmarketing Commitments.
Clinical Trial Transparency
AbbVie is committed to transparency regarding the clinical trials it sponsors and recognizes there are important public health benefits in making clinical trial information available to health care providers, patients, and the general public. Therefore, AbbVie has adopted national and international principles and standards regarding disclosure of information about our clinical trials.
For AbbVie's approach to sharing information with regard to its clinical research, see AbbVie Transparency Policy on Clinical Research.
AbbVie registers clinical trial protocol information and discloses results of clinical trials, regardless of outcome, in a publicly accessible clinical trials registry (www.clinicaltrials.gov). Additionally, clinical trial protocol information submitted by AbbVie to the EudraCT database is made publicly available by the EMA via the clinical trials register at www.clinicaltrialsregister.eu. See AbbVie Transparency Policy on Clinical Research for further detail.
Prior to the availability of disclosing clinical trial results for pharmaceuticals on www.clinicaltrials.gov, AbbVie (prior sponsor, Abbott) disclosed certain clinical trial results on the Clinical Study Results Database created by the Pharmaceutical Research and Manufacturers of America (PhRMA), (www.ClinicalStudyResults.org); however, this database was phased out on 20 December 2011. The clinical trial information previously posted to www.ClinicalStudyResults.org through August 2011 is available via this link and is organized via the generic name of the product.
